SpecialPandemic puts a Gulf AI company on the cutting edge of genome research
- Genetic analysis to help scientists better understand origins of COVID-19, identify variants and improve testing
- If successful, Abu Dhabi-based G42 Healthcare’s Hayat-Vax will make the UAE the first Arab country to produce a COVID-19 vaccine
